Reshma Malviya

发表

Safety and efficacy of an extended‐release peptide YY analogue for obesity: A randomized, placebo‐controlled, phase 1 trial

B. Khoo, S. Bloom, T. Tan, 2021, Diabetes, obesity & metabolism.

Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial

J. Minnion, K. Alexiadou, Sirazum Choudhury, 2024, Diabetes, obesity & metabolism.